Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Pharma Mar SA
MAD:PHM
Pharma Mar SA
MAD:PHM
Price:
70.8
EUR
2.24%
Market Cap:
€1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pharma Mar SA
MAD:PHM
|
ES |
|
R
|
Ross Stores Inc
DUS:RSO
|
US |
|
S
|
Strata Critical Medical Inc
NASDAQ:SRTA
|
US |
|
Aberdeen Group PLC
F:T3V0
|
UK |
|
S
|
SoftBank Corp
OTC:SOBKY
|
JP |
|
C
|
CapitaLand Integrated Commercial Trust
F:M3T
|
SG |
|
B
|
Bts Group Holdings PCL
SET:BTS
|
TH |
Wall St Price Targets
PHM Price Forecast
Based on 12 analysts
Based on 12 analysts
+44% Upside
from
€70.8
today
Pharma Mar SA (PHM)’s 12-month stock price forecast through October 2027 has a consensus target of €102, implying 44% upside. The forecast is based on price targets from 12 Wall Street analysts.
PHM Analyst Rating
No ratings yet
No ratings yet
Pharma Mar SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHM's stock price target?
Price Target
102
EUR
102
EUR
According to Wall Street analysts, the average 1-year price target for PHM is 102 EUR with a low forecast of 63.29 EUR and a high forecast of 131.25 EUR.
What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 19%.
What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
26%
26%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 26%.
What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
46%
46%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 46%.
What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.